IPO追蹤 | 融創服務計劃將香港IPO價格定在指導價區間中點附近
uSMART盈立智投11月12日消息,據彭博報道,融創服務據悉計劃將香港IPO價格定在指導價區間中點附近。
融創服務招股價區間爲10.55-12.65港元,若以中間價11.6港元定價,則上市市值爲348億港元,在港股已上市的物業股中排名第四,次於世茂服務,對應PE(TTM)約63倍。
融創服務是中國增長最快的大型物業管理商,在管面積過億,將躋身物業龍頭陣營。收購開元物業後,提升盈利空間和外拓能力。背靠融創中國,土儲面積充足,未來業績確定性高。過去3年收入和利潤年複合增長率59.5%、150.7%,高瓴、雪湖、IDG、騰訊爲基石,共認購32.85-39.39%發售股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.